Lucid Diagnostics Inc.
LUCDNASDAQHealthcare● Active
$0.99
+$0.03(+3.01%)
Market Cap$100964157
P/E Ratio—
52W High$1.629
52W Low$0.9
Lucid Diagnostics Inc.（LUCD）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LUCD · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($58.01M) | ($45.53M) | ($52.67M) | ($56.17M) | ($28.08M) |
| Depreciation & Amort. | $0.87M | $1.17M | $2.50M | $1.94M | $0.00M |
| Stock-Based Comp. | $4.49M | $4.53M | $6.82M | $14.99M | $9.60M |
| Change in Working Capital | ($2.81M) | ($4.43M) | $5.67M | $8.91M | $0.81M |
| Net Cash from Operations | ($46.48M) | ($44.14M) | ($32.82M) | ($29.68M) | ($17.67M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.20M) | ($0.65M) | ($0.22M) | ($0.91M) | ($0.86M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.20M) | ($0.65M) | ($0.22M) | ($4.11M) | ($0.86M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.36M | $18.00M | $10.00M | $0.00M | $0.00M |
| Net Cash from Financing | $59.03M | $48.25M | $29.46M | $2.61M | $72.08M |
| Free Cash Flow | |||||
| Free Cash Flow | ($46.48M) | ($44.79M) | ($33.04M) | ($30.59M) | ($18.53M) |
| FCF Margin %(computed) | -987.78% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Lucid Diagnostics Inc.
关于Lucid Diagnostics Inc.（LUCD）现金流量表
Lucid Diagnostics Inc. 2025财年经营活动现金流($0.05B)，自由现金流($0.05B)（FCF利润率-987.78%），资本支出($0.00B)。
常见问题
LUCD · 4 问Lucid Diagnostics Inc. 2025财年自由现金流($0.05B)，同比down3.8%。
LUCD free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10